Saturday, May 15, 2021 6:59:30 PM
Rag on Doc Williams all you want.
Doc Williams wasn't even @ AP when the Topline data readout was made public.
Nor did he interpret the data on behalf of AP. That was the Statisticians job right?
What we do know is Doc Williams is not a part of a Team of Cobras with a long history of pennyland companies that have gone up in smoke and flamed out.
55
ROTFLMAO
As to Team Cobra having “brought in a different team…” I have no idea what you’re talking about. It’s the same team minus Doc Williams now. How was Doc Williams MIA during his tenure @ AP? Are you confusing him with Rajpaul, Michael, or David - the "Ghost Ship" Board of Directors?
CJM 12/15/2020
CJM 12/17/2020
CJM 12/30/2020
CJM 02/10/2021
Attention: Fire in COVID-19 Hospital in Second World Country of Romania delays the Topline Data readout.
75% of ALL COVID-19 patient records were stored in the Romania hospital!
OOPS
Data Delay Delay Delay Delay
I wonder if Doc Williams had a heavy hand in that “SUPER cost effective” decision to go All In in Romania?
Just like All In in Australia & New Zealand!
Oh Look!
Three and One Half Months (3.5) after receiving COVID-19 Interim Data we finally get COVID-19 Topline Data:
CJM 03/31/2021
Meanwhile...the data drips are for sale to any newbies giving AP a new look.
However, longs know all that's new @ AP is all that's old @ AP.
S.O.S. different day for more dilution in the offering.
Here's AP's money making CEO strutting his stuff like a pennyland peacock when no one's around:
www.youtube.com/watch?v=yMK1YMXu35A
Furthermore, who is still not aware of the fact the clinical trial data is independently analysed? One attempts to make it sound like the data results all fall/fell on the CSO shoulders. It does not, did not, and will not. CJM is the dude out front (CEO) playing with the data one way or another in the webcasts. Go back and read GVX808's last post. 808 gets the big picture just like many others that are in tune with the facts.
Last point about Doc Williams. Simply look at his pedigree besides his college degrees (Ph.D, MBA). Does anybody know if the CEO Moreau even has a high school diploma? However, I digress. Doc Williams last biotech gig prior to joining AP in a takeover by Nash Pharmaceuticals (said to be a subsidiary of Breathtec Biomedical) was DiaMedica Therapeutics. They trade on NASDAQ. Their 6 month stock chart shows a share price of approximately $4 to $10 USD. That equates to a market cap of $75M USD to $187M USD. Their current market cap is $122M USD. DiaMedica Therapeutics is effectively a one compound (DM199) one trick pony biotech company. Doc Williams is a co-inventor of DM199. It should also come as no surprise that AP went the route of Ischemic Stroke with it's DMT program. Especially when one considers the "CEO" left it in the hands of Doc Williams to brainstorm a clinical trial pathway for DMT. @ Diamedica, DM199 is being evaluated in a clinical trial for Acute Ischemic Stroke.
Who Knew?!
While we're on the topic of compounds let's see whose name is on ALL relevant patents @ AP to date:
patentscope.wipo.int/search/en/result.jsf?_vid=P11-KOPQQ6-17036
patentscope.wipo.int/search/en/result.jsf?_vid=P11-KOPQQ6-17036
I count 16 patents for Doc Williams and 0 (Zero) patents for Team Cobra @ AP.
We have a CEO who talked about a $500M CAD market cap @ AP at this “Inflection Point” of the process (Phase II Data Readout). He also said "Everybody want's in at Phase II" - CJM, CEO @ AP
^That being said - should we expect a share price increase from the teen cents (10 to 19 cent usd) to $3 USD = $3.63 CAD before another PP for Pals and/or the start of Phase III?
Thus far all we can expect to get out of tacky Mackie and Research Capi is sh!t getting ever more wacky.
04/01/2021 Mackie Research: 25 Cent CAD “HOLD”.
www.cantechletter.com/2021/04/take-a-pass-on-algernon-pharmaceuticals-says-mackie/
05/11/2021 Research Capital: 25 Cent CAD “SPECULATIVE BUY”.
www.cantechletter.com/2021/05/algernon-upgraded-at-research-capital/
Andre Uddin is the same analyst at Mackie Research and Research Capital dropping bombs on the rooftop of AP.
Nick Wadell (Author) is the autopilot for the AP BOMBS AWAY messaging across multiple platforms:
Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.
My guess is Andre Uddin & Nick Wadell (Tag Team) will keep pounding the same message over and over again at least until we get feedback from the EOP2 meeting.
Meanwhile...not one word from the AP bunker about the pundits pounding out loud.
I wonder who would stand to gain the most from such a consistent pounding of the chest?
Perhaps the King Kong of Penny Flippers?
Who Knows...right?
AYO!
Make the call - to get the call - for when we all - can expect an “analyst” to call for $3 USD @ AP.
M$
PostScript from the other side of Dante's Inferno:
He made it out Alive with his reputation intact and 16 AP Patents Pending.
Outro
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM